NCT01780636View on ClinicalTrials.gov

Ultrasound and EMG Guided Botox Injection for the Treatment of Non-Relaxing Puborectalis Syndrome

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

July 31, 2014

Conditions
Non-relaxing Puborectalis Syndrome
Interventions
DRUG

botulinum toxin

Trial Locations (1)

92868

University of California, Irvine Medical Center, Orange

Sponsors

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

American Urogynecologic Society

OTHER

collaborator

Allergan

INDUSTRY

lead

Karen Noblett

OTHER